Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why Harvard Bioscience Is Poised to Pop

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical instruments maker Harvard Bioscience (NASDAQ: HBIO  ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Harvard Bioscience and see what CAPS investors are saying about the stock right now.

Harvard Bioscience facts

Headquarters (founded)

Holliston, Mass. (1901)

Market Cap

$132.3 million


Life sciences tools and services

Trailing-12-Month Revenue

$112.0 million


Chairman/CEO Chane Graziano
CFO Thomas McNaughton

Return on Equity (average, past 3 years)



$20.3 million / $15.3 million


Becton Dickinson
Bio-Rad Laboratories
Thermo Fisher Scientific

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 96% of the 166 members who have rated Harvard Bioscience believe the stock will outperform the S&P 500 going forward.

This past weekend, one of those bulls, All-Star TMFDeej, helped bring the special opportunity to our community's attention:

Harvard Bioscience is in the process of spinning off its money-losing HART division, leaving behind a manufacturer of scientific instruments trading for only three times earnings, yet growing at 15% to 20% per year. See Jim Royal's great article on the situation for more information.

If you want to retire rich, you need to put together the best portfolio you can. Of course, despite its five-star rating, Harvard Bioscience may not be your top choice.

We've found another growth play we are incredibly excited about -- excited enough to dub it "The Only Stock You Need to Profit from the NEW Technology Revolution." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2207386, ~/Articles/ArticleHandler.aspx, 10/1/2016 11:39:06 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 14 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 4:00 PM
HBIO $2.72 Down -0.02 -0.73%
Harvard Bioscience CAPS Rating: ***
BDX $179.73 Up +3.29 +1.86%
Becton Dickinson CAPS Rating: ****
BIO $163.81 Up +1.85 +1.14%
Bio-Rad Laboratori… CAPS Rating: *****
TMO $159.06 Up +3.00 +1.92%
Thermo Fisher Scie… CAPS Rating: ****